Self-reported symptoms in French primary care SARS-CoV-2 patients: association with gender and age group.


Journal

Family practice
ISSN: 1460-2229
Titre abrégé: Fam Pract
Pays: England
ID NLM: 8500875

Informations de publication

Date de publication:
27 Aug 2021
Historique:
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 3 9 2021
Statut: ppublish

Résumé

The early identification of COVID-19 patients is of outmost importance in the current pandemic. As with other pathogens, presenting symptoms of SARS-CoV-2 may vary, depending on sociodemographic factors. We aimed to describe the clinical characteristics of COVID-19 patients by age/gender and to assess whether the diagnostic performance of these symptoms varied according to these variables. We analysed data from a cross-sectional study involving primary care patients undergoing RT-PCR testing in Lyon, France. Among patients who tested positive, we examined whether there was an association between age/gender and various symptoms. In addition, we calculated the diagnostic performance of the most specific symptoms (smell/taste disorder). Among 1543 consecutive patients, 253 tested positive (16%). There were significant age/gender-related differences in symptoms. In middle-aged women, the diagnostic performance of smell/taste disorders were AUC = 0.65 [95%CI 0.59-0.71] and PPV = 72% [95%CI 53-87%], that is higher than in the entire sample (smell/taste disorders: AUC = 0.59 [95%CI 0.57-0.62] and PPV = 57% [95%CI 47-67%]. In contrast, the negative predictive values of smell/taste disorders were similar in both groups (85% [95%CI 81-89%] for middle-age women and 86% [95%CI 85-88%] for the entire sample). We found significant age/gender-related differences in the clinical characteristics of COVID-19 patients. Screening strategies based on smell/taste disorders performed better in middle-aged women, but could not ensure a diagnosis of COVID-19 in any subgroup of patients. Future diagnostic strategies should use age/gender differentiated approaches.

Identifiants

pubmed: 34448483
pii: 6358431
doi: 10.1093/fampra/cmab009
pmc: PMC8513396
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

i37-i44

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Am J Geriatr Pharmacother. 2010 Feb;8(1):47-62
pubmed: 20226392
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Asian Pac J Allergy Immunol. 2020 Jun;38(2):69-77
pubmed: 32563234
CMAJ. 2020 Jun 29;192(26):E702-E707
pubmed: 32461325
J Investig Allergol Clin Immunol. 2020;30(5):346-357
pubmed: 32554337
CJEM. 2020 Sep;22(5):595-602
pubmed: 32507123
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
Laryngoscope. 2007 Feb;117(2):272-7
pubmed: 17277621
J Med Virol. 2020 Jun;92(6):612-617
pubmed: 32108351
Int Forum Allergy Rhinol. 2020 Aug;10(8):955-962
pubmed: 32410386
J Gen Intern Med. 2020 Aug;35(8):2502-2504
pubmed: 32519322
Sci Rep. 2020 Nov 13;10(1):19765
pubmed: 33188232
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
J Infect. 2020 Dec;81(6):937-943
pubmed: 32998038
Pneumologie. 2019 Oct;73(10):605-616
pubmed: 31622999
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
BMJ. 2020 Dec 2;371:m4529
pubmed: 33268329
J Korean Med Sci. 2020 May 11;35(18):e174
pubmed: 32383370
ORL J Otorhinolaryngol Relat Spec. 2020;82(4):175-180
pubmed: 32526759
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Curr Allergy Asthma Rep. 2020 Oct 13;20(12):76
pubmed: 33048282
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Clin Geriatr Med. 2016 Aug;32(3):523-38
pubmed: 27394021
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
Rural Remote Health. 2020 Sep;20(3):6325
pubmed: 32955912
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343
pubmed: 32253888

Auteurs

Paul Sebo (P)

Primary Care Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Hubert Maisonneuve (H)

Primary Care Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
University College of General Medicine, University Claude Bernard Lyon 1.
Mermoz Primary Health Centre, Lyon, France.

Julie Lourdaux (J)

Cerballiance Rhône-Alpes Laboratory, Lyon, France.

Clara Cuzin (C)

University College of General Medicine, University Claude Bernard Lyon 1.

Martin Floquet (M)

University College of General Medicine, University Claude Bernard Lyon 1.

Benoit Tudrej (B)

University College of General Medicine, University Claude Bernard Lyon 1.
Mermoz Primary Health Centre, Lyon, France.

Dagmar M Haller (DM)

Primary Care Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH